CD38 and leukemia: In the CD34+CD38–TIM3+CD99+ leukemia stem cell–enriched (LSC-enriched) fraction, RUNX1mut LSCs (SU371) exhibited higher expression of IL-3RA compared with matched RUNX1wt LSCs (SU524, SU770) (Figure 5H).